SUPPLEMENT

Q4 2021 — Condensed Consolidated Statement of Earnings

Q4 2021PDF · 2 pages28 KB
Johnson & Johnson and Subsidiaries
Condensed Consolidated Statement of Earnings
(Unaudited; in Millions Except Per Share Figures)
Percent
Percent 	Percent 	Increase
Amount 	to Sales 	Amount 	to Sales 	(Decrease)
Sales to customers 	24,804	$ 	100.0 	22,475	$ 	100.0 	10.4
Cost of products sold 	7,955 	32.1 	7,814 	34.8 	1.8
Gross Profit 	16,849 	67.9 	14,661 	65.2 	14.9
Selling, marketing and administrative expenses 	7,154 	28.9 	6,457 	28.7 	10.8
Research and development expense 	4,720 	19.0 	4,032 	17.9 	17.1
In-process research and development 	0 	0.0 	37 	0.2
Interest (income) expense, net 	47 	0.2 	74 	0.3
Other (income) expense, net 	9 	0.0 	2,354 	10.5
Restructuring 	83 	0.3 	60 	0.3
Earnings before provision for taxes on income 	4,836 	19.5 	1,647 	7.3 	193.6
Provision for/(Benefit from) taxes on income 	100 	0.4 	(91) 	(0.4) 	(209.9)
Net earnings 	4,736	$ 	19.1 	1,738	$ 	7.7 	172.5
Net earnings per share (Diluted) 	1.77	$ 	0.65	$ 	172.3
Average shares outstanding (Diluted) 	2,670.2 	2,669.2
Effective tax rate 	2.1 % 	(5.5) %
Adjusted earnings before provision for taxes and net earnings (1)
Earnings before provision for taxes on income 	6,339	$ 	25.6 	5,601	$ 	24.9 	13.2
Net earnings 	5,678	$ 	22.9 	4,965	$ 	22.1 	14.4
Net earnings per share (Diluted) 	2.13	$ 	1.86	$ 	14.5
Effective tax rate 	10.4 % 	11.4 %
(1) See Reconciliation of Non-GAAP Financial Measures.
FOURTH QUARTER
2021 	2020

-- 1 of 2 --

Johnson & Johnson and Subsidiaries
Condensed Consolidated Statement of Earnings
(Unaudited; in Millions Except Per Share Figures)
Percent
Percent 	Percent 	Increase
Amount 	to Sales 	Amount 	to Sales 	(Decrease)
Sales to customers 	93,775	$ 	100.0 	82,584	$ 	100.0 	13.6
Cost of products sold 	29,855 	31.8 	28,427 	34.4 	5.0
Gross Profit 	63,920 	68.2 	54,157 	65.6 	18.0
Selling, marketing and administrative expenses 	24,659 	26.3 	22,084 	26.8 	11.7
Research and development expense 	14,714 	15.7 	12,159 	14.7 	21.0
In-process research and development 	900 	1.0 	181 	0.2
Interest (income) expense, net 	130 	0.1 	90 	0.1
Other (income) expense, net 	489 	0.5 	2,899 	3.5
Restructuring 	252 	0.3 	247 	0.3
Earnings before provision for taxes on income 	22,776 	24.3 	16,497 	20.0 	38.1
Provision for taxes on income 	1,898 	2.0 	1,783 	2.2 	6.4
Net earnings 	20,878	$ 	22.3 	14,714	$ 	17.8 	41.9
Net earnings per share (Diluted) 	7.81	$ 	5.51	$ 	41.7
Average shares outstanding (Diluted) 	2,674.0 	2,670.7
Effective tax rate 	8.3 % 	10.8 %
Adjusted earnings before provision for taxes and net earnings (1)
Earnings before provision for taxes on income 	30,464	$ 	32.5 	25,428	$ 	30.8 	19.8
Net earnings 	26,195	$ 	27.9 	21,433	$ 	26.0 	22.2
Net earnings per share (Diluted) 	9.80	$ 	8.03	$ 	22.0
Effective tax rate 	14.0 % 	15.7 %
(1) See Reconciliation of Non-GAAP Financial Measures.
TWELVE MONTHS
2021 	2020

-- 2 of 2 --